27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Gainers
- Enlivex Therapeutics, Inc. (NASDAQ:ENLV) stock surged 27.5% to $11.88 during Monday's pre-market session. The most recent rating by H.C. Wainwright, on January 09, is at Buy, with a price target of $20.00.
- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) shares surged 20.1% to $2.15.
- Lianluo Smart, Inc. (NASDAQ:LLIT) stock moved upwards by 15.7% to $0.76.
- Cleveland BioLabs, Inc. (NASDAQ:CBLI) stock surged 13.1% to $2.25.
- Novavax, Inc. (NASDAQ:NVAX) stock increased by 11.1% to $8.58.
- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) stock rose 11.1% to $4.16. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.
- Tocagen, Inc. (NASDAQ:TOCA) stock surged 10.5% to $2.10.
- Co-Diagnostics, Inc. (NASDAQ:CODX) shares rose 8.8% to $3.32. The most recent rating by HC Wainwright & Co., on February 24, is at Buy, with a price target of $4.00.
- Correvio Pharma, Inc. (NASDAQ:CORV) stock surged 7.0% to $0.31. According to the most recent rating by H.C. Wainwright, on December 11, the current rating is at Neutral.
- Allied Healthcare Prods, Inc. (NASDAQ:AHPI) stock increased by 6.1% to $2.61.
Losers
- Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) shares decreased by 8.2% to $0.21 during Monday's pre-market session.
- Trillium Therapeutics, Inc. (NASDAQ:TRIL) shares declined 8.1% to $3.84.
- Galapagos, Inc. (NASDAQ:GLPG) shares decreased by 7.6% to $253.22. The most recent rating by HC Wainwright & Co., on February 24, is at Buy, with a price target of $302.00.
- DBV Technologies, Inc. (NASDAQ:DBVT) stock decreased by 7.5% to $9.18. The most recent rating by Stifel, on January 09, is at Buy, with a price target of $18.00.
- Viveve Medical, Inc. (NASDAQ:VIVE) shares plummeted 7.4% to $1.38. According to the most recent rating by Ladenburg Thalmann, on December 03, the current rating is at Buy.
- Cronos Group, Inc. (NASDAQ:CRON) stock declined 6.8% to $6.66.
- Schrodinger, Inc. (NASDAQ:SDGR) shares declined 6.4% to $46.80.
- Aurora Cannabis, Inc. (NYSE:ACB) stock declined 6.3% to $1.56. The most recent rating by Piper Sandler, on January 10, is at Underweight, with a price target of $1.00.
- Genprex, Inc. (NASDAQ:GNPX) stock plummeted 5.2% to $5.05.
- Onconova Therapeutics, Inc. (NASDAQ:ONTX) stock fell 4.9% to $0.50.
- MorphoSys, Inc. (NASDAQ:MOR) shares decreased by 4.4% to $29.54.
- Danaher, Inc. (NYSE:DHR) shares declined 4.4% to $154.70. The most recent rating by Needham, on February 03, is at Buy, with a price target of $187.00.
- Rockwell Medical, Inc. (NASDAQ:RMTI) stock declined 4.4% to $3.06.
- Alcon, Inc. (NYSE:ALC) shares declined 4.3% to $60.77. The most recent rating by Morgan Stanley, on December 17, is at Overweight, with a price target of $70.00.
- OPKO Health, Inc. (NASDAQ:OPK) shares declined 4.3% to $1.56.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!